GG News Bureau
New Delhi, 3rd May. The parents of a young girl who passed away after receiving Covishield are preparing to take legal action against the world’s largest vaccine manufacturer and the British pharmaceutical company that developed it during the Covid pandemic. This decision comes after AstraZeneca acknowledged in court documents in the UK that their vaccine can lead to rare side effects such as blood clots and low platelet count.
The AstraZeneca vaccine, known as Covishield, was produced in India by the Serum Institute of India (SII) and was widely distributed there.
SII has not yet commented on this issue.
Venugopalan Govindan, who tragically lost his 20-year-old daughter Karunya in 2021, expressed that the admission from AstraZeneca came too late and after many lives had already been lost.
In a social media post, he mentioned that the Serum Institute should have halted the vaccine supply after 15 European countries restricted its use due to clot-related deaths. He stated that the grieving parents are seeking justice through various legal avenues but have not received a fair hearing.
If adequate remedies are not obtained, we will pursue legal action against all those responsible for the deaths of our children to ensure justice and prevent such tragedies from happening again, Mr. Govindan stated, echoing the sentiments of eight other families affected by this issue.
Serum Institute of India and Adar Poonawalla will be held accountable for their actions, Mr. Govindan wrote online, also blaming government authorities for approving the vaccine rollout.
Rachana Gangu, who lost her 18-year-old daughter Rithaika in 2021, along with Mr. Govindan, had previously filed a petition in the Supreme Court requesting the establishment of a medical board to investigate their daughters’ deaths, develop a protocol for early detection of vaccination side effects, and seek compensation.
AstraZeneca is currently facing a collective lawsuit in the UK involving at least 51 cases alleging that its vaccine caused deaths and severe injuries. The company recently acknowledged that in extremely rare instances, its vaccine can lead to TTS (Thrombosis with Thrombocytopenia Syndrome), resulting in blood clots and low platelet count.
The UK government, which has legal protection for AstraZeneca, has not yet intervened in this matter.
Comments are closed.